**CERTIFICATION**

|   | 1. | I                have reviewed this annual report on Form 10-KSB of Bio Solutions                Manufacturing, Inc.; |
|--------|----|----------------------------------------------------------------------------------------------------------------------------|

|   | 2. | Based                on my knowledge, this annual report does not contain any untrue statement                of a material fact or omit to state a material fact necessary to                make the                statements made, in light of the circumstances under which such statements                were made, not misleading with respect to the period covered by this                annual report; |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 3. | Based                on my knowledge, the financial statements, and other financial information                included in this annual report, fairly present in all material respects                the financial condition, results of operations and cash flows of                Bio                Solutions Manufacturing, Inc. as of, and for, the periods presented                in this annual report; |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 4. | Bio                Solutions Manufacturing, Inc.’s other certifying officer and I are                responsible for establishing and maintaining disclosure controls                and                procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))                for Bio Solutions Manufacturing, Inc. and we have done the                following: |
|--------|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | a. | designed                such disclosure controls and procedures, or caused such disclosure                controls and procedures to be designed under our supervision, to                ensure                that material information relating to Bio Solutions                Manufacturing, Inc., including its consolidated subsidiaries, is made                known to us by others within those entities, particularly during                the                period in which this annual report is being                prepared; |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | b. | designed                such internal control over financial reporting, or caused such internal                control over financial reporting to be designed under our supervision,                to                provide reasonable assurance regarding the reliability of financial                reporting and the preparation of financial statements for external                purposes in accordance with generally accepted accounting                principles; |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | c. | evaluated                the effectiveness of Bio Solutions Manufacturing, Inc.’s disclosure                controls and procedures and presented in this annual report our                conclusions about the effectiveness of the disclosure controls and                procedures, as of the end of the period covered by this report based                on                such evaluation; and |
|--------|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | d. | disclosed                in this annual report any change in Bio Solutions Manufacturing,                Inc.’s                internal control over financial reporting that occurred during Bio                Solutions Manufacturing, Inc.’s fourth fiscal quarter that has materially                affected, or is reasonably likely to materially affect, Bio Solutions                Manufacturing, Inc.’s internal control over financial reporting;                and |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 5. | Bio                Solutions Manufacturing, Inc.’s other certifying officer and I have                disclosed, based on our most recent evaluation of internal control                over                financial reporting, to Bio Solutions Manufacturing, Inc.’s auditors and                the audit committee of the Bio Solutions Manufacturing, Inc.’s board of                directors: |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | a. | All                significant deficiencies and material weaknesses in the design or                operation of internal control over financial reporting which are                reasonably likely to adversely affect Bio Solutions Manufacturing,                Inc.’s                ability to record, process, summarize and report financial information;                and |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | b. | Any                fraud, whether or not material, that involves management or other                employees who have a significant role in Bio Solutions Manufacturing,                Inc.’s internal control over financial                reporting. |
|--------|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  March                22, 2007 |    |                        /s/ Patricia                Spreitzer                                                          Patricia                SpreitzerTreasurer,                Secretary, and Chief Financial Officer(Principal                Financial Officer) |
|-------------------------------------|--------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|